biuro@scopefluidics.com
+48 22 376 21 14
About
Team
Our offer
Knowledge base
News
Investor relations
Career
Contact
biuro@scopefluidics.com
+48 22 376 21 14
About
Team
Our offer
Knowledge base
News
Investor relations
Career
Contact
biuro@scopefluidics.com
+48 22 376 21 14
RAPORT ESPI 7/2020 | 17-01-2020 | Zawiadomienia o zmianie stanu posiadania akcji Spółki
Previous Post
RAPORT ESPI 6/2020 | 16-01-2020 | Otrzymanie zawiadomień, o których mowa w art. 19 ust. 1 MAR
Next Post
RAPORT ESPI 8/2020 | 24-01-2020 | Zawiadomienia o zmianie stanu posiadania akcji Spółki
0
Shares
Related Posts
15.10.2026
Edocera develops device prototype and confirms its ability to detect signs of stroke
SCOPE FLUIDICS
0
30.09.2026
Scope Fluidics after the first half of 2026: strong cash position, IVDR certification and expanding cooperation with distributors
SCOPE FLUIDICS
0
28.09.2026
Hybolic signs PARP funding agreement to develop a system for measuring insulin and glucose concentrations
SCOPE FLUIDICS
0
